unknown
Stage
About
Unleash Immuno Oncolytics develops armed oncolytic viruses that target both tumor cells and tumor-associated stromal cells to disrupt tumor architecture and activate systemic immune responses against cancer.
Explore Unleash Immuno Oncolytics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.